<scp>ACSL3</scp> Promotes Hepatocellular Carcinoma Tumorigenesis and Correlates With <scp>JAK</scp> – <scp>STAT3</scp> Signaling
These findings underscore ACSL3 as a significant biomarker and candidate therapeutic target in HCC. Its role bridges dysregulated lipid metabolism with oncogenic signaling and immune evasion, warranting further investigation into ACSL3-targeted strategies.
Authors
- Alireza Pourmahdian (ORCID: https://orcid.org/0000-0002-7381-1870)
- Mandana Amelimojarad
- Zhang Lu
Institutions
- Liaoning University (CN)
- Iran University of Medical Sciences (IR)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/cam4.71543
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 0.00